Trial Profile
A Pilot, Open-Label, Randomized, Crossover, Pharmacokinetic Study Of Enhanced Bioavailability Formulations Of Celecoxib In Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Acute pain; Ankylosing spondylitis; Back pain; Breast cancer; Cervicobrachial syndrome; Dental pain; Dysmenorrhoea; Familial adenomatous polyposis; Gouty arthritis; Juvenile rheumatoid arthritis; Musculoskeletal pain; Non-small cell lung cancer; Osteoarthritis; Pain; Periarthritis; Postoperative pain; Rheumatic disorders; Rheumatoid arthritis; Small cell lung cancer; Stomatitis; Tendinitis; Tenosynovitis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 12 Mar 2009 Actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.
- 12 Mar 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2009 Planned initiation date changed from 1 Jan 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.